Balance Sheet Dive: AdaptHealth Corp (AHCO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

After finishing at $10.60 in the prior trading day, AdaptHealth Corp (NASDAQ: AHCO) closed at $9.76, down -7.92%. In other words, the price has decreased by -$7.92 from its previous closing price. On the day, 3.34 million shares were traded. AHCO stock price reached its highest trading level at $10.115 during the session, while it also had its lowest trading level at $9.0.

Ratios:

Our goal is to gain a better understanding of AHCO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.13. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.21. In the meantime, Its Debt-to-Equity ratio is 1.57 whereas as Long-Term Debt/Eq ratio is at 1.51.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on January 08, 2024, Downgraded its rating to Hold and sets its target price to $8 from $14.50 previously.

On November 08, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $9.50 to $6.50.

Stifel Downgraded its Buy to Hold on May 10, 2023, whereas the target price for the stock was revised from $18 to $11.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 12 ’24 when Flynn James E sold 114,906 shares for $10.70 per share. The transaction valued at 1,229,494 led to the insider holds 11,528,863 shares of the business.

Flynn James E sold 182,607 shares of AHCO for $2,012,557 on Mar 11 ’24. The 10% Owner now owns 11,643,769 shares after completing the transaction at $11.02 per share. On Mar 08 ’24, another insider, Flynn James E, who serves as the 10% Owner of the company, sold 52,487 shares for $10.93 each. As a result, the insider received 573,652 and left with 11,826,376 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AHCO now has a Market Capitalization of 1307186048 and an Enterprise Value of 3630066176. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.41 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at 1.134 whereas that against EBITDA is 5.645.

Stock Price History:

Over the past 52 weeks, AHCO has reached a high of $15.37, while it has fallen to a 52-week low of $6.37. The 50-Day Moving Average of the stock is -5.30%, while the 200-Day Moving Average is calculated to be 4.77%.

Shares Statistics:

The stock has traded on average 1.16M shares per day over the past 3-months and 978370 shares per day over the last 10 days, according to various share statistics. A total of 132.63M shares are outstanding, with a floating share count of 71.01M. Insiders hold about 46.98% of the company’s shares, while institutions hold 58.22% stake in the company. Shares short for AHCO as of 1713139200 were 7269037 with a Short Ratio of 6.27, compared to 1710460800 on 8291020. Therefore, it implies a Short% of Shares Outstanding of 7269037 and a Short% of Float of 7.000000000000001.

Most Popular

[the_ad id="945"]